Suchergebnisse - "Thrower, B"

PubPharm (7)

1

Symptom burden, management and treatment goals of people with MS spasticity : Results from SEEN-MSS, a large-scale, self-reported survey

enthalten in: Multiple sclerosis and related disorders | 2022

von Newsome, S. | Thrower, B. | Hendin, B. | +3

2

Effect of in-painting on cortical thickness measurements in multiple sclerosis : A large cohort study

enthalten in: Human brain mapping | 2015

von Govindarajan, K. | Datta, S. | Hasan, K. | +95

3

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis : Results of open-label extensions of two Phase 3 clinical trials

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2015

von Goodman, A. | Bethoux, F. | Brown, T. | +55

4

Regional gray matter atrophy in relapsing remitting multiple sclerosis : baseline analysis of multi-center data

enthalten in: Multiple sclerosis and related disorders | 2015

von Datta, S. | Staewen, T. | Cofield, S. | +94

5

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

enthalten in: Annals of neurology | 2013

von Lublin, F. | Cofield, S. | Cutter, G. | +95

CommentIn: Ann Neurol. 2013 Mar;73(3):A5-6. - PMID 23596013

6

Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis : 96-week results

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2009

von Giovannoni, G. | Barbarash, O. | Casset-Semanaz, F. | +57

7

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study) : a multicentre, randomised, parallel, open-label trial

enthalten in: The Lancet. Neurology | 2008

von Mikol, D. | Barkhof, F. | Chang, P. | +89

CommentIn: Lancet Neurol. 2008 Oct;7(10):864-6. - PMID 18789767

1
[1]